Building better beta cells.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 18397747.
- Also identified by DOI 10.1016/j.stem.2008.03.011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Type 1 diabetes represents an attractive target for human embryonic stem cell (hESC)-based cell replacement therapies. Recently, in Nature Biotechnology, Kroon et al. (2008) reported encouraging progress toward this goal with the development of functional islet-like structures in mice transplanted with hESC-derived pancreatic endoderm.
Medical subject headings
- Embryonic Stem Cells
- Insulin-Secreting Cells